Risk of autoimmune dseases (AD) after human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine immunization in women aged 9 to 25 years in the United Kingdom: An observational cohort study

Manel Pladevall-Vila; C Willame; D Rosillon; J Zima; MG Angelo; A Stuurman; H Vroling; T van Staa; R Boggon; E Bunge; Manel Pladevall-Vila; L Baril

Risk of autoimmune dseases (AD) after human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine immunization in women aged 9 to 25 years in the United Kingdom

An observational cohort study

Willame, C., Rosillon, D., Zima, J., Angelo, MG., Stuurman, A., Vroling, H., van Staa, T., Boggon, R., Bunge, E., Pladevall-Vila, M., & Baril, L. (2015). Risk of autoimmune dseases (AD) after human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine immunization in women aged 9 to 25 years in the United Kingdom: An observational cohort study. Pharmacoepidemiology and Drug Safety, 24(Supplement: 1), 409.

Copy citation